Competitive inhibition of histone deacetylase activity by trichostatin A and butyrate.
about
Dietary, metabolic, and potentially environmental modulation of the lysine acetylation machineryEssential roles of four-carbon backbone chemicals in the control of metabolismEpigenetics of inflammation, maternal infection, and nutritionDietary factors and epigenetic regulation for prostate cancer preventionDietary phytochemicals, HDAC inhibition, and DNA damage/repair defects in cancer cellsAcetylation of core histones in response to HDAC inhibitors is diminished in mitotic HeLa cells.Ketone bodies as signaling metabolites.Suberoylanilide hydroxamic acid (SAHA)-induced dynamics of a human histone deacetylase protein interaction networkA gnotobiotic mouse model demonstrates that dietary fiber protects against colorectal tumorigenesis in a microbiota- and butyrate-dependent manner.Dietary manipulation of histone structure and function.Metabolism as a key to histone deacetylase inhibition.Targeting the epigenome: Screening bioactive compounds that regulate histone deacetylase activity.The Warburg effect dictates the mechanism of butyrate-mediated histone acetylation and cell proliferationEpigenetic silencing of CREB3L1 by DNA methylation is associated with high-grade metastatic breast cancers with poor prognosis and is prevalent in triple negative breast cancers.Cholesterylbutyrate solid lipid nanoparticles as a butyric acid prodrug.Acetylation and deacetylation of Cdc25A constitutes a novel mechanism for modulating Cdc25A functions with implications for cancer.Modulation of histone deacetylase activity by dietary isothiocyanates and allyl sulfides: studies with sulforaphane and garlic organosulfur compounds.Alpha-keto acid metabolites of organoselenium compounds inhibit histone deacetylase activity in human colon cancer cells.Elucidating the interactions between the human gut microbiota and its host through metabolic modeling.Targeting class I histone deacetylases in cancer therapy.Metabolic regulation of histone post-translational modifications.The role of butyrate, a histone deacetylase inhibitor in diabetes mellitus: experimental evidence for therapeutic intervention.Histone and Non-Histone Targets of Dietary Deacetylase Inhibitors.Hypothesis: butyrate is not an HDAC inhibitor, but a product inhibitor of deacetylation.Deacetylase inhibitors dissociate the histone-targeting ING2 subunit from the Sin3 complex.Sulforaphane Reverses the Expression of Various Tumor Suppressor Genes by Targeting DNMT3B and HDAC1 in Human Cervical Cancer Cells.Roles of histone deacetylases in epigenetic regulation: emerging paradigms from studies with inhibitorsTrichostatin A decreases the levels of MeCP2 expression and phosphorylation and increases its chromatin binding affinity.Impact of Phytochemicals and Dietary Patterns on Epigenome and Cancer.Loss of FFAR2 promotes colon cancer by epigenetic dysregulation of inflammation suppressors.Strategies to enhance the production of pinoresinol and its glucosides by endophytic fungus (Phomopsis sp. XP-8) isolated from Tu-chung bark.The effect of combined treatment with sodium phenylbutyrate and cisplatin, erlotinib, or gefitinib on resistant NSCLC cells
P2860
Q21296850-5FD2920E-7B0C-422A-A8F6-DA4AE2D9A685Q26795753-19041E64-2538-49C6-B69B-06590EE1ED9BQ26828350-CB9BFB93-3C7A-46A9-8BD0-84BBD77BDC97Q26991774-DA49ED77-75D0-48DA-BCDA-16B88372D892Q28257534-848B35B1-0CFA-418A-AD95-09CD7675E8E3Q34122502-D9E998E4-70EA-4DCE-8DD5-CAD718588F2CQ34252732-2351D883-2C78-4A06-A126-21C5A639B9E9Q34468386-94A2CA53-CC0E-4DBC-AF75-D4EE6FB5BEACQ34644406-1B1077F2-15FE-491D-976B-771DE9FCDABBQ34898711-96F00868-66AD-484A-9319-70CDFE676F26Q35661981-C646AD01-805F-4144-A0F0-F1FCA371F7EDQ36226378-4A150C89-685B-4E53-A297-31370CCE959BQ36442568-C52E05B5-C4F1-4955-A00E-15BAF2072E01Q36503782-22F85F2C-EE0C-4EB9-A8D3-03AAA9B37EC7Q37096490-63516890-DDF6-45A2-B35D-7572EFB92B23Q37190330-34E125A3-D96F-4D32-9D4F-0DAB0946738BQ37240767-E3115A9E-8EF4-4928-B685-6F837DF9538BQ37281699-81B1FAE0-BEEC-41B1-A2E3-489C0D72CCDFQ37725583-B41EEACD-1478-48C7-83D8-836CB9C0160EQ38051736-3F330539-5978-4C78-BB20-96BC05EC5BC3Q38308759-59B6BFE5-DEF9-4AC1-B3C7-BF5D48BE5A2EQ38537774-BC44B1E0-DDEE-44C3-90D6-31088877A280Q38572921-9A896958-CEDC-4E47-A0A7-886BF5FD47D8Q39636878-3D145687-5463-407D-8097-8B70BA7E1D5EQ39742002-EA59CE90-7897-4E95-97D9-890B78CC0E8EQ40751870-20A7915B-D8B5-4388-B317-2FD6DDA993B4Q42555454-0A984E87-0ED9-45F3-87C1-C882B3BD51FFQ47445768-C4250C93-9758-461A-B54A-588FE1C969FBQ51187064-E60CEA35-5E24-4FC5-8605-458D26BEE440Q51417749-1196AB57-BF1B-418C-8085-1DAC5DB388E2Q54940060-620FA016-EFAB-432D-8EEE-4484EA973349Q57816535-0500B44B-14F3-465A-86A1-5BF50AEE097C
P2860
Competitive inhibition of histone deacetylase activity by trichostatin A and butyrate.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Competitive inhibition of histone deacetylase activity by trichostatin A and butyrate.
@en
type
label
Competitive inhibition of histone deacetylase activity by trichostatin A and butyrate.
@en
prefLabel
Competitive inhibition of histone deacetylase activity by trichostatin A and butyrate.
@en
P2093
P2860
P356
P1476
Competitive inhibition of histone deacetylase activity by trichostatin A and butyrate.
@en
P2093
Anoushe Sekhavat
James R Davie
Jian-Min Sun
P2860
P304
P356
10.1139/O07-145
P577
2007-12-01T00:00:00Z